We did a comprehensive review of all the initial public offerings for the biotech and pharmaceutical industry in 2021. This article is Part 1 in a review series about companies focused on drug discovery that IPO’d during this time.
You can find recent years’ IPOs summarized here:
this content is exclusive to
Premium members
Unlock this content with a Premium membership to read it now.
